Cargando…

Prospective, Case-Control Study of Serological Response after Two Doses of BNT162b2 anti-SARS-CoV-2 mRNA Vaccine in Transfusion-Dependent Thalassemic Patients

Detalles Bibliográficos
Autores principales:	Sgherza, Nicola, Zucano, Stefania, Vitucci, Angelantonio, Palma, Antonio, Tarantini, Francesco, Campanale, Daniela, Vimercati, Luigi, Larocca, Angela Maria Vittoria, Visceglie, Domenico, Acquafredda, Amalia, Ostuni, Angelo, Di Gennaro, Daniela, Vitucci, Carmen, Tafuri, Silvio, Musto, Pellegrino
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2022
Materias:	Scientific Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266603/ https://www.ncbi.nlm.nih.gov/pubmed/35865398 http://dx.doi.org/10.4084/MJHID.2022.056

Ejemplares similares

Serological Response to BNT162b2 Anti-Sars-Cov-2 mRNA Vaccine in Patients with Transfusion Dependent Thalassemia
por: Zucano, Stefania, et al.
Publicado: (2021)

Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine is not influenced by AB0 blood group in subjects with transfusion-dependent thalassemia
por: Sgherza, Nicola, et al.
Publicado: (2022)

“Hemolysis, or not Hemolysis, that is the Question”. Use of Hydroxychloroquine in a Patient with COVID-19 Infection and G6PD Deficiency
por: Sgherza, Nicola, et al.
Publicado: (2020)

COVID-19 in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): An Observational Retrospective Study
por: Sgherza, Nicola, et al.
Publicado: (2021)

Serological Response Following BNT162b2 Anti-Sars-Cov-2 mRNA Vaccination in Hematopoietic Stem Cell Transplantation Patients
por: Attolico, Imma, et al.
Publicado: (2021)

Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study
por: Sgherza, Nicola, et al.
Publicado: (2021)

Hypereosinophilia with a pinch of salt and pepper
por: Vitucci, Angelantonio, et al.
Publicado: (2021)

SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
por: Sgherza, Nicola, et al.
Publicado: (2022)

Humoral Immune Response after anti-SARS-CoV-2 Vaccine “Booster” Dose in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS)
por: Sgherza, Nicola, et al.
Publicado: (2023)

Medium-to-Long-Term Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine: A Retrospective Cohort Study
por: Bianchi, Francesco Paolo, et al.
Publicado: (2022)

P1319: T AND B LYMPHOCYTES SUBSETS AFTER BNT162B2 ANTI-SARS-COV-2 M-RNA VACCINATION: A COMPARISON BETWEEN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS AND HEALTHY CONTROLS.
por: Attolico, I., et al.
Publicado: (2022)

Immune response to one dose of BNT162b2 mRNA Covid-19 vaccine followed by SARS-CoV-2 infection: An Italian prospective observational study()
por: Stefanizzi, Pasquale, et al.
Publicado: (2022)

P948: INCIDENCE AND CLINICAL OUTCOME OF SARS-COV-2 INFECTION AFTER VACCINATION IN PATIENTS WITH MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE (MGUS)
por: Sgherza, N., et al.
Publicado: (2022)

On the role of tail in stability and energetic cost of bird flapping flight
por: Ducci, Gianmarco, et al.
Publicado: (2022)

BNT162b2 mRNA COVID-19 Vaccine Effectiveness in the Prevention of SARS-CoV-2 Infection and Symptomatic Disease in Five-Month Follow-Up: A Retrospective Cohort Study
por: Bianchi, Francesco Paolo, et al.
Publicado: (2021)

Study of behavioral problems in multi-transfused thalassemic children
por: Hongally, Chandrashekar, et al.
Publicado: (2012)

Direct antiglobulin test positivity in multi-transfused thalassemics
por: Jain, Ashish, et al.
Publicado: (2016)

Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients
por: Fianza, Pandji Irani, et al.
Publicado: (2021)

Effects of Different Types of Chronic Training on Bioenergetic Profile and Reactive Oxygen Species Production in LHCN-M2 Human Myoblast Cells
por: Mancini, Annamaria, et al.
Publicado: (2022)

P1586: COMPARISON OF FREQUENCY OF TRANSFUSION RELATED COMPLICATIONS IN THALASSEMIC AND NON-THALASSEMIC PATIENTS RECEIVING NON LEUKODEPLETED RED CELL CONCENTRATE.
por: Imran, Tanzeel, et al.
Publicado: (2023)

Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
por: Reiter, Rieke, et al.
Publicado: (2022)

Safety of heterologous ChAdOx1-S/BNT162b2 primary schedule versus homologous BNT162b2 vaccination: Insights from an Italian post-marketing study, 2021
por: Fortunato, Francesca, et al.
Publicado: (2023)

Efficacy and Safety of Wheat Grass in Thalassemic Children on Regular Blood Transfusion
por: Mutha, Amit S, et al.
Publicado: (2018)

Desferioximine induced Ototoxicity in Thalassemic patients
por: Vir, Dharam, et al.
Publicado: (2010)

Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
por: Sgherza, Nicola, et al.
Publicado: (2021)

High Frequency of Post-Transfusion Microchimerism Among Multi-Transfused Beta-Thalassemic Patients
por: Matsagos, Spyridon, et al.
Publicado: (2022)

Antispike Immunoglobulin-G (IgG) Titer Response of SARS-CoV-2 mRNA-Vaccine (BNT162b2): A Monitoring Study on Healthcare Workers
por: Inchingolo, Alessio Danilo, et al.
Publicado: (2022)

Immunogenicity and safety of BNT162b2 mRNA COVID-19 vaccine in a subject affected by Shapiro’s syndrome: A case report
por: Moscara, Lorenza, et al.
Publicado: (2022)

Influence of Sport Practice and Body Weight on Physical Fitness in Schoolchildren Living in the Campania Region
por: Mancini, Annamaria, et al.
Publicado: (2022)

Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
por: Barocci, Simone, et al.
Publicado: (2022)

SARS-CoV-2 infection in fully vaccinated patients with multiple myeloma
por: Sgherza, Nicola, et al.
Publicado: (2021)

The Antioxidant Effect of Erythropoietin on Thalassemic Blood Cells
por: Amer, Johnny, et al.
Publicado: (2010)

The Reproductive Behavior of Families with Thalassemic Children in Hormozgan
por: Safari Moradabadi, Ali, et al.
Publicado: (2015)

Outcome of iron reduction therapy in ex-thalassemics
por: Aboobacker, Fouzia N., et al.
Publicado: (2021)

Perception of Parents of Thalassemic Child to Thalassemia in Pakistan
por: Saleem, Noman, et al.
Publicado: (2021)

Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
por: Azzi, Lorenzo, et al.
Publicado: (2021)

Neutralizing Activity of BNT162b2-Elicited Serum
por: Liu, Yang, et al.
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j8673jiedbh9dt5gf98a0bs61m